Pain after uterine artery embolization with intrauterine device .

Uterine artery embolization (UAE) is a minimally invasive option for females with symptomatic leiomyomas. Studies detailing a possible risk with an intrauterine device (IUD) during UAE are limited. A 43-year-old female (Gravida 2, Para 2) underwent UAE with an IUD .

Cervical intraepithelial neoplasia grade 3 in a patient following Gardasil vaccination.

Essentially all cervical dysplasia is caused by human papilloma virus (HPV). Three HPV vaccines have been available, with Gardasil-9 being the most recently approved in the USA. Gardasil-9 covers high-risk HPV strains 16, 18, 31, 33, 45, 52 and 58 as well as low-risk strains 6 and 11.

Pregnancy after uterine artery embolization using Gelfoam™.

We present a case study of a patient who underwent uterine artery embolization (UAE) using Gelfoam™ (Pfizer, New York, NY, USA) and had a subsequent pregnancy. Our patient, a 38-year-old female (4 Gravida/2 Para), underwent UAE for treatment of symptomatic myoma in September 2005. At the patient's seven-month post procedure visit, she experienced a 43.

Anti-Müllerian hormone levels before and after uterine artery embolization.

Objective: To determine the effects of uterine artery embolization (UAE) on ovarian reserve as measured by Anti-Müllerian hormone (AMH) levels.

Material And Methods: Non-randomized, observational study of 89 women 23-40 years of age who received UAE. Control hormone levels were measured prior to UAE and the first post-embolization measurement was taken at various times post-procedure (mean = 190 ± 229 days).

Fertility after uterine artery embolization: a review.

Uterine artery embolization (UAE) research has largely been focused on women over 40 years, yet women of reproductive age undergo UAE without any increased morbidity. Some physicians refrain from recommending UAE to women in this age group because of some research findings showing a negative effect on fertility. This review presents a comprehensive discussion of the fertility potential of women undergoing UAE, in terms of pregnancy rates and complications as well as ovarian function and reserve.

The effectiveness of combined abdominal myomectomy and uterine artery embolization.

Objective: To evaluate the efficacy of abdominal myomectomy after uterine artery embolization (UAE-AM) among patients with myomas.

Methods: In a retrospective study, chart data were reviewed for patients attending a center in California, USA, who underwent UAE-AM between 1999 and 2012. Patients had been offered the combined procedure if the diameter of the myoma was at least 4cm, they wished to preserve fertility, or they were candidates for a traditional abdominal myomectomy.

Anti Müllerian hormone levels before and after uterine artery embolization: A preliminary report.

Objective: To determine the effects of uterine artery embolization on Anti-Müllerian hormone levels for women under 40 years of age.

Material And Methods: Non-randomized, observational study of women under 40 years of age and who received UAE. Twenty-seven women under the age of 40 who underwent UAE were included in the study.

Combined myomectomy and uterine artery embolization.

Unlabelled: Objective: To evaluate the safety and efficacy of uterine artery embolization combined with endoscopic myomectomy.

Material And Methods: We conducted a retrospective chart review of patients (n = 125) who underwent myomectomy concurrent with embolization within one month. We assessed two groups: 1) uterine artery embolization followed by hysteroscopic myomectomy and 2) uterine artery embolization followed by laparoscopic myomectomy.

Results of UAE in women under 40 years of age.

Objective: To evaluate the success rate of uterine artery embolization for leiomyomata for women under 40 years of age.

Material And Methods: This observational study of fibroid treatment in women under 40 years of age at the time of procedure was conducted at a private practice located in Los Angeles, CA. One hundred and four patients participated in the study.

Ovarian reserve following uterine artery embolization in women of reproductive age: a preliminary report.

Objective: To evaluate the effect of uterine artery embolization (UAE) for leiomyomata on reproductive potential for women in their reproductive age group.

Material And Methods: This non-randomized, cross-sectional, observational study of ovarian reserve in women under 40 years of age who underwent UAE was conducted at a private practice located in Los Angeles, California. Twenty four women under 40 years of age who underwent UAE at least four months prior to study interventions were recruited.

Pregnancy following uterine artery embolization: an update.

Objective: This paper seeks to evaluate the ability to conceive and deliver term pregnancies following uterine artery embolization.

Methods: We conducted a retrospective chart review of patients under the age of 40 who indicated a desire for fertility prior to embolization. Patients were questioned regarding attempts to conceive, subsequent pregnancies, and outcomes of those pregnancies.

Three-dimensional reconstruction of the uterine vascular supply through vascular casting and thin slice computed tomography scanning.

It was the objective of this study to construct a model of the uterine vascular supply through vascular casting and thin slice computed tomography scanning. This will provide a teaching aide for the understanding of uterine artery embolization (UAE) procedures, as well as normal uterine and ovarian arterial anatomy. Using 20% chlorinated poly vinyl chloride, we infused and cast a set of a normal uterus, vagina and bilateral adnexa through the uterine artery and ovarian artery.

Repeat uterine artery embolization following technical failure.

This retrospective chart review was performed to evaluate the success of uterine artery embolization performed in two sessions due to initial technical failure. Patients undergoing embolization for symptomatic uterine myomata between 1997 and 2007 were included in the study. Patients who initially suffered unilateral technical failure were offered repeat embolization.

Computed tomography angiogram for failed uterine artery embolization.

It was the aim of this study to discuss the efficacy of computed tomography angiography after failed uterine artery embolization. We performed a review of cases where embolization of myomata failed to relieve symptoms, or shrink myomata. If MRI showed continued uptake, patients were offered CT angiograms to better direct therapy.

Acquisition of endovascular skills for uterine artery embolization using a simulator.

This study addresses endovascular training using simulators for uterine artery embolization. A review of endovascular skill training for surgeons using simulators was performed. Surgeons possess varying levels of proficiency in endovascular techniques.

Extra-gonadal collateral supply to uterine leiomyomata: a case report.

Although the vast majority of uterine leiomyomata are supplied solely by the uterine arteries, myomata have been reported to recruit additional blood supply, especially from the ovarian arteries. This report describes a patient with vascular supply to uterine leiomyomata from a non-gonadal source. The collateral supply was identified during uterine artery embolization as originating from an aortoiliac hemorrhoidal artery emanating from the inferior mesenteric artery.

Collateral supply to uterine leiomyomata from an unnamed vessel: a case report.

Uterine leiomyomata are most often supplied solely by the uterine arteries. However, myomata have been reported to recruit collateral supply, usually from the ovarian arteries, which may contribute to clinical failure of uterine artery embolization. This case report describes a patient in whom a uterine myoma developed collateral supply de novo.

Repeat uterine artery embolization following poor results.

It was the objective of this study to assess the efficacy of repeat uterine artery embolization following lack of symptom relief from initial procedure. We performed a retrospective chart review of patients undergoing embolization for symptomatic uterine myomata between 1994 and 2007. Success was defined based upon responses to symptom-relief questionnaires.

Myoma necrosis following Gelfoam embolization of uterine myomata.

The aim of this study was to assess the risk and clinical significance of purulent necrosis following Gelfoam uterine artery embolization in the minimally invasive management of uterine leiomyomata. This study compares the incidence of purulent necrosis in leiomyomata affecting women who underwent Gelfoam embolization with those who had embolization with traditional particles. From January 20 to May 26, 2005, 54 patients were embolized for symptomatic fibroids.